


YD Bio Limited Revenue
Biotechnology Research • Bothell, Washington, United States • 1-10 Employees
YD Bio Limited revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | $13,200,000 |
Key Contact at YD Bio Limited
Doug Ramsey
Imdependent Director (Nasdaq:YDES)
Company overview
| Headquarters | 21720 23rd Dr SE, Bothell, Washington 98021, US |
| Phone number | +886223820330 |
| Websites | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
YD Bio Limited Email Formats
YD Bio Limited uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@ydesgroup.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@ydesgroup.com | 100% |
About YD Bio Limited
YD Bio Limited (Nasdaq: YDES) is a biotechnology company pioneering transformative solutions from early cancer detection to next-generation cell therapies to improve and extend patient lives. Our mission is to redefine healthcare by making breakthrough diagnostics and regenerative therapies accessible to patients everywhere. Areas of Focus: Cancer Detection – Non-invasive tools for early detection, treatment monitoring, and recurrence tracking for earlier interventions and better outcomes. Ophthalmologic Products – Innovative solutions addressing large unmet needs in dry eye comfort to improve quality of life. Exosome-Based Therapeutics – Advancing regenerative science to deliver long-term solutions for complex diseases and healthier futures.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Frequently asked questions
4.8
40,000 users



